L-/N-type Calcium Channel Blockers and Proteinuria

ISSN: 1875-6506 (Online)
ISSN: 1573-4021 (Print)


Volume 10, 4 Issues, 2014


Download PDF Flyer




Current Hypertension Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Prof. Kazuomi Kario
Jichi Medical University
School of Medicine
Japan


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


L-/N-type Calcium Channel Blockers and Proteinuria

Author(s): Katsuyuki Ando

Affiliation: Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, 7-3- 1 Hongo, Bunkkyo-ku, Tokyo, 113-8655, Japan.

Abstract

The first-line depressor agents for hypertensive patients with chronic kidney disease are the renin-angiotensin system inhibitors because of their antiproteinuric and reno-protective effects. However, only one renin-angiotensin system inhibitor often cannot achieve target blood pressure in patients with injured kidney. Thus, second-line antihypertensives are required. Calcium channel blockers are frequently added on the renin-angiotensin system inhibitors in hypertensive patients with chronic kidney disease. However, they do not always show reno-protective effects because of their glomerular pressure-increasing action; Antihypetensive calcium channel blockers suppress L-type calcium channels, which exist in glomerular afferent but not efferent arterioles, and their afferent arteriole-specific vasodilation causes glomerular hypertension. The decrease in glomerular pressure due to their systemic hypotesive effect is counteracted by the glomerular pressure-incresing action. However, L-/N-type calcium channel blockers inhibits norepinephrine release from the sympathetic nerve terminal by blockade of N-type calcium channels, and dilate both afferent and efferent arterioles, which were innervated sympathetically, resulting in decrease in glomerular pressure. Actually, we have demonstrated that an L-/N-type calcium channel blocker cilnidipine decreased urinary protein more greatly than an L-type calcium channel blocker amlodipine in the renin-angiotensin system inhibitor-treated patients with chronic kidney disease. Thus, L-/N-type calcium channel blockers are one of suitable candidates for the second-line antihypertensives in the renin-angiotensin system inhibitor-treated hypertensive patients with proteinuria.

Keywords: N-type calcium channel, chronic kidney disease, afferent arteriole, glomerular pressure, sympathetic nervous system.

Download Free Rights and Permissions

  
  



Article Details

Volume: 9
Issue Number: 3
First Page: 210
Last Page: 218
Page Count: 9
DOI: 10.2174/1573402110666140131155331
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science